Literature DB >> 28029501

Declining mortality due to severe sepsis and septic shock in Spanish intensive care units: A two-cohort study in 2005 and 2011.

B Sánchez1, R Ferrer2, D Suarez3, E Romay1, E Piacentini1, G Gomà4, M L Martínez4, A Artigas4.   

Abstract

OBJECTIVE: To analyze the evolution of sepsis-related mortality in Spanish Intensive Care Units (ICUs) following introduction of the Surviving Sepsis Campaign (SSC) guidelines and the relationship with sepsis process-of-care.
DESIGN: A prospective cohort study was carried out, with the inclusion of all consecutive patients presenting severe sepsis or septic shock admitted to 41 Spanish ICUs during two time periods: 2005 (Edusepsis study pre-intervention group) and 2011 (ABISS-Edusepsis study pre-intervention group). SCOPE: Patients with severe sepsis or septic shock admitted to Spanish ICUs. PATIENTS: All ICU admissions from the emergency department or wards and all ICU patients with a diagnosis of severe sepsis or septic shock. A total of 1348 patients were included: 630 in the 2005 group and 718 in the 2011 group. INTERVENTION: None. PRIMARY ENDPOINTS: ICU mortality, 28-day mortality and Hospital mortality, hospital length of stay, ICU length of stay and compliance with the resuscitation bundle.
RESULTS: Compliance with the resuscitation bundle was significantly greater in the 2011 group (5.7% vs. 9.9%; p=0.005), and was associated to lower mortality (OR 0.602 [0.365-0.994]; p=0.048). The 2011 group had lower absolute in-hospital mortality (44.0% vs. 32.6%; p=0.01), 28-day mortality (36.5% vs. 23.0%; p=0.01), and adjusted mortality (OR 0.64 [0.49-0.83], p=0.001).
CONCLUSIONS: Mortality related to severe sepsis or septic shock in Spain decreased between two patient cohorts in 2005 and 2011, and was attributable to earliness and improvement in sepsis care.
Copyright © 2016 Elsevier España, S.L.U. y SEMICYUC. All rights reserved.

Entities:  

Keywords:  Critical care; Guidelines; Guías; Medicina intensiva; Mortalidad; Mortality; Sepsis

Mesh:

Year:  2016        PMID: 28029501     DOI: 10.1016/j.medin.2016.09.004

Source DB:  PubMed          Journal:  Med Intensiva        ISSN: 0210-5691            Impact factor:   2.491


  3 in total

1.  The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure.

Authors:  Ignacio Martin-Loeches; Arturo Muriel-Bombín; Ricard Ferrer; Antonio Artigas; Jordi Sole-Violan; Leonardo Lorente; David Andaluz-Ojeda; Adriele Prina-Mello; Ruben Herrán-Monge; Borja Suberviola; Ana Rodriguez-Fernandez; Pedro Merino; Ana M Loza; Pablo Garcia-Olivares; Eduardo Anton; Eduardo Tamayo; Wysali Trapiello; Jesús Blanco; Jesús F Bermejo-Martin
Journal:  Ann Intensive Care       Date:  2017-04-20       Impact factor: 6.925

2.  Improved empirical antibiotic treatment of sepsis after an educational intervention: the ABISS-Edusepsis study.

Authors:  Ricard Ferrer; María Luisa Martínez; Gemma Gomà; David Suárez; Luis Álvarez-Rocha; María Victoria de la Torre; Gumersindo González; Rafael Zaragoza; Marcio Borges; Jesús Blanco; Eduardo Palencia Herrejón; Antonio Artigas
Journal:  Crit Care       Date:  2018-06-22       Impact factor: 9.097

3.  Long non-coding RNA-HOTAIR promotes the progression of sepsis by acting as a sponge of miR-211 to induce IL-6R expression.

Authors:  Jianan Chen; Xingsheng Gu; Li Zhou; Shuguang Wang; Limei Zhu; Yangneng Huang; Feng Cao
Journal:  Exp Ther Med       Date:  2019-09-27       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.